Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
letter
. 2020 May 7;251:272–274. doi: 10.1016/j.ejogrb.2020.05.004

Re: Novel Coronavirus COVID-19 in late pregnancy: Outcomes of first nine cases in an inner city London hospital

A Govind a, S Essien a, A Karthikeyan a, A Fakokunde a, D Janga a, W Yoong a,, A Nakhosteen b
PMCID: PMC7204671  PMID: 32402627

We would like to share our experience of nine laboratory-proven COVID-19 mothers delivered at a London inner-city hospital between 7th of March and 22nd April 2020. In all cases, positive diagnosis was based on real time reverse transcriptase polymerase chain reaction (RT-PCR) of maternal nasopharygeal swabs.

The median age and gestation at delivery were 31 years (range 18–39) and 39 weeks (range 27–39) respectively and two of the nine women were delivered by emergency caesarean section (CS) for COVID-19 pneumonia and deteriorating maternal respiratory function. Of the remaining seven, one mother had a normal vaginal delivery, six underwent elective CS for obstetric indications while an emergency CS was performed in one woman for suboptimal cardiotocography (Table 1 ). Seven of our nine women (78 %) had mild to moderate prodromal symptoms not requiring admission (such as fever, cough, myalgia, sore throat, anosmia): these women were only screened due to a high index of suspicion rather than severity of complaints. The infants were immediately isolated from the mothers at birth and had RT-PCR for SARS-Cov-2 nucleic acid nasal pharyngeal swabs performed. Only one of the nine babies was subsequently confirmed as COVID-19 positive (patient 1) based on nasopharyngeal RT-PCR.

Table 1.

showing maternal and fetal outcomes (n = 9).

Patient Age (yrs) Parity CXR Gestation (wks) Mode of delivery Indication PMH Fever Cough Myalgia and joint pains Runny nose Sore throat Lethargy Dyspnoea Anosmia Fetal weight (g) Fetal COVID status Fetal outcome
1 36 2 + 0 Consolidation 38 Em CS Maternal pneumonia and respiratory distress Gestational diabetes Y Y N N Y Y Y N 4165 Positive Viral pneumonia day 6 but recovered well
Apgars 5, 9
2 29 2 + 1 Consolidation 27 Em CS Maternal pneumonia and respiratory distress None Y Y N N N N Y Y 1200 Negative Ventilated for 10 days
Apgars 2, 6
3 31 2 + 3 Normal 35 Em CS Pathological CTG not in labour None Y Y Y N Y Y Y Y 2700 Negative Observation only due to poor feeding
Apgars 6, 8
4 31 0 + 1 Consolidation 39 El CS Breech Asthma Y N N N Y N N Y 3370 Negative Talipes
Apgars 9, 9
5 22 1 + 0 Consolidation 38 NVD N/A None N Y Y N N Y N N 4300 Negative Well
Apgars 9, 9
6 39 4 + 1 Not done 37 El CS 3 previous CS Insulin dependent diabetes hypertension N Y N N N Y N Y 2500 Negative Well
Apgars 8, 9
7 18 1 + 0 Not done 39 El CS Previous CS and maternal request None N Y Y N N N N Y 3060 Negative Well
Apgars 9, 9
8 38 3 + 1 Not done 39 El CS 3 previous CS None N Y Y N Y Y Y Y 3540 Negative Well
Apgars 9, 9
9 34 0 + 0 Not done 39 El CS Maternal request None N Y Y N N Y N Y 3560 Negative Well
Apgars 9, 9

We would like to focus on the first two mothers who were delivered by emergency CS due to inability to maintain oxygen saturation and to highlight the accompanying lymphopenia that were previously described in the cases reported by Sutton [1] and Zheng [2].

Patient 1: A 33 year old woman with diet controlled gestational diabetes mellitus was admitted at 39 weeks gestation with flu-like symptoms and productive cough. A provisional diagnosis of pneumonia was made but she developed chest pain and became tachypnoeic. Chest Xray revealed right basal consolidation and lymphopenia was noted (0.92 × 109/l; normal: 1.2–3.6). Maternal nasopharygeal swabs were positive for SARS-CoV-2 RT-PCR and she underwent an emergency CS for sudden deterioration of respiratory function, requiring 15 L/min of oxygen to maintain saturation of >95 %. A live infant 4.165 kgs was delivered with Apgar scores of 51minute and 95 minutes and was immediately separated from the mother. Following delivery, the patient continued to desaturate (80–85 %) on 100 % of oxygen and was transferred to a tertiary centre for extracorporeal membrane oxygenation (ECMO). The baby, subsequently confirmed as COVID-19 positive, developed pyrexia and exhibited signs of pneumonia on the sixth day but settled with benzylpenicillin and gentamycin.

Patient 2: A 29 year old lady was admitted at 27 weeks gestation with myalgia, cough, pyrexia >38.4 °C and dyspnoea. SARS-CoV-2 was diagnosed on basis of nasopharyngeal RT-PCR and chest Xray showed basal consolidation (Fig. 1 ). She was commenced on intravenous clarithromycin and cefuroxime but became tachypnoeic and was unable to maintain oxygen saturation. Lymphopenia (1.05 × 109 /l; normal: 1.2–3.6) was noted and an emergency CS was performed for deteriorating maternal respiratory function. She required mechanical ventilation for four days post-delivery before being “stepped down”. The baby weighing 1.2 kgs with Apgars of 21minute and 65 minutes and required intubation because of prematurity. The baby was negative for nasopharyngeal, amniotic fluid and placental swabs RT-PCR for SARS-CoV-2 and was weaned off ventilation after 10 days.

Fig. 1.

Fig. 1

Chest Xray of patient 2 showing lower lobe patchy consolidation consistent with (COVID) pneumonia.

Table 1 shows that maternal symptoms can be variable and of interest is that cough (8/9) and anosmia (7/9) appear to be the commonest presentations in this small series. We had initially followed advice from Chinese literature which recommended isolation of the infected woman and her baby for 14 days [2]. However, given the limited data and considering the potential detrimental effects on feeding and bonding, the Royal Colleges of Midwifery and Obstetricians and Gynaecologists have now jointly issued a guideline [3] that COVID-19 women and their healthy babies should be kept together in the postpartum period. Similarly, breast milk of affected mothers [4] has tested negative for COVID-19 and current evidence suggest that breast feeding is not contraindicated [3].

The most recent systemic review of six studies involving 48 delivered women indicates low likelihood of vertical transmission [5], although transplacental maternal-fetal transmission have been reported [1,2] including in our first case (where mother and baby were immediately separated and membranes had remained intact until CS). We can postulate that there may be a relationship between vertical transmission with maternal viral load as this was our most respiratory-compromised patient.

The same systemic review [5] noted that 96 % of COVID-19 women were delivered by CS; however, we suspect that these were likely to be elective procedures for obstetric indications, like the last four women in our series, where COVID-19 had been detected several weeks prior to delivery in relatively stable patients.

We end this letter by reminding clinicians that many pregnant women with COVID-19 present with mild or even no symptoms. In the United Kingdom, we currently do not have the capacity or funds to screen all pregnant women as recommended by Sutton et al. [1] but any recent onset of cough and anosmia warrants a high level of suspicion for screening.

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References


Articles from European Journal of Obstetrics, Gynecology, and Reproductive Biology are provided here courtesy of Elsevier

RESOURCES